Asia Pacific Infusion Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The Asia Pacific infusion devices market is projected to grow significantly, reaching approximately US$ 5,490.48 million by 2031, up from US$ 3,014.20 million in 2023, reflecting a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2023 to 2031.

Executive Summary and Market Analysis

The Asia Pacific region, which includes countries such as China, Japan, India, Australia, South Korea, and others, is experiencing rapid growth in the infusion devices market. This growth is driven by several factors, including the increasing number of market players introducing innovative and cost-effective products, supportive initiatives from local governments, and a rising incidence of chronic diseases like cancer and diabetes. The presence of local manufacturers also enhances the accessibility of infusion devices across the region.

Market Segmentation

The Asia Pacific infusion devices market can be segmented based on product type, application, and end user.

1. Product Type: The market is divided into infusion pumps and infusion sets. In 2023, infusion pumps dominated the market share. Within infusion pumps, the segments include volumetric pumps, syringe pumps, insulin pumps, patient-controlled analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps, with volumetric pumps holding the largest share. Infusion sets are categorized into vented and non-vented sets, with vented sets leading in market share.

2. Application: The market is further segmented by application into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others. Diabetes applications accounted for the largest market share in 2023.

3. End User: The end users of infusion devices include hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others, with hospitals and specialty clinics representing the largest segment in 2023.

Market Outlook

Key players in the Asia Pacific infusion devices market are focusing on strategic initiatives such as product launches, mergers, acquisitions, and collaborations to enhance their offerings for chronic conditions like diabetes, cancer, and chronic pain. Recent developments include:

In February 2023, Mindray introduced the BeneFusion i Series and u Series infusion systems, designed for high precision and safety in medication delivery across various clinical environments.
In March 2022, Fresenius Kabi received FDA clearance for its Agilia Connect Infusion System, which includes advanced volumetric and syringe pumps equipped with Vigilant Software Suite technology.
Eitan Medical launched operations in the UK in January 2021 to better support its Sapphire infusion pump customers, including NHS Trusts and private healthcare providers.

These advancements indicate a growing trend of product approvals and strategic partnerships, which are expected to create significant opportunities in the infusion devices market.

Country Insights

The Asia Pacific infusion devices market is notably influenced by country-specific dynamics. China emerged as the largest market in 2023. For instance, in October 2021, EOFlow Co., Ltd. established a joint venture with Changsha Sinocare Co., Ltd. to penetrate the expanding Chinese diabetes market, focusing on the production and distribution of the EOPatch, a wearable insulin pump. Additionally, China imported over 2 million infusion pumps valued at US$ 0.235 million in 2023, ranking second among the top importers of infusion pumps. The increasing prevalence of chronic diseases necessitating infusion therapies is propelling market growth in China.

Company Profiles

Key players in the Asia Pacific infusion devices market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Elimedical Inc, Fresenius Kabi AG, ICU Medical Inc, KD Scientific Inc, Medtronic Plc, Moog Inc, Nipro Corp, Polymedicure, Tandem Diabetes Care Inc, Terumo Corp, and Zimed Healthcare Ltd, among others. These companies are actively pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their market presence and deliver innovative solutions to consumers.

Product Code: BMIRE00032020

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Asia Pacific Infusion Devices Market Landscape

4.1 PEST Analysis

5. Asia Pacific Infusion Devices Market - Key Market Dynamics

5.1 Asia Pacific Infusion Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Cancer
- 5.2.2 Growing Geriatric Population
5.3 Market Restraints
- 5.3.1 Frequent Product Recalls of Infusion Devices
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Growing Technological Advancements
5.6 Impact of Drivers and Restraints:

6. Asia Pacific Infusion Devices Market - Analysis

6.1 Asia Pacific Infusion Devices Market Revenue (US$ Million), 2021-2031
6.2 Asia Pacific Infusion Devices Market Forecast Analysis

7. Asia Pacific Infusion Devices Market Analysis - by Product Type

7.1 Infusion Pumps
- 7.1.1 Overview
- 7.1.2 Infusion Pumps: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Infusion Sets
- 7.2.1 Overview
- 7.2.2 Infusion Sets: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Infusion Devices Market Analysis - by Application

8.1 Diabetes
- 8.1.1 Overview
- 8.1.2 Diabetes: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Oncology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Hematology
- 8.4.1 Overview
- 8.4.2 Hematology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Pediatrics
- 8.5.1 Overview
- 8.5.2 Pediatrics: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Gastroenterology
- 8.6.1 Overview
- 8.6.2 Gastroenterology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Infusion Devices Market Analysis - by End User

9.1 Hospitals and Specialty Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Specialty Clinics: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Homecare Settings
- 9.2.1 Overview
- 9.2.2 Homecare Settings: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Infusion Devices Market - Country Analysis

10.1 Asia Pacific
- 10.1.1 Asia Pacific Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Asia Pacific Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 China: Asia Pacific Infusion Devices Market Share - by Product Type
    - 10.1.1.2.2 China: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.2.3 China: Asia Pacific Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.2.4 China: Asia Pacific Infusion Devices Market Share - by Application
    - 10.1.1.2.5 China: Asia Pacific Infusion Devices Market Share - by End User
  - 10.1.1.3 Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Japan: Asia Pacific Infusion Devices Market Share - by Product Type
    - 10.1.1.3.2 Japan: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.3.3 Japan: Asia Pacific Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.3.4 Japan: Asia Pacific Infusion Devices Market Share - by Application
    - 10.1.1.3.5 Japan: Asia Pacific Infusion Devices Market Share - by End User
  - 10.1.1.4 India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 India: Asia Pacific Infusion Devices Market Share - by Product Type
    - 10.1.1.4.2 India: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.4.3 India: Asia Pacific Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.4.4 India: Asia Pacific Infusion Devices Market Share - by Application
    - 10.1.1.4.5 India: Asia Pacific Infusion Devices Market Share - by End User
  - 10.1.1.5 Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.5.1 Australia: Asia Pacific Infusion Devices Market Share - by Product Type
    - 10.1.1.5.2 Australia: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.5.3 Australia: Asia Pacific Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.5.4 Australia: Asia Pacific Infusion Devices Market Share - by Application
    - 10.1.1.5.5 Australia: Asia Pacific Infusion Devices Market Share - by End User
  - 10.1.1.6 South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.6.1 South Korea: Asia Pacific Infusion Devices Market Share - by Product Type
    - 10.1.1.6.2 South Korea: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.6.3 South Korea: Asia Pacific Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.6.4 South Korea: Asia Pacific Infusion Devices Market Share - by Application
    - 10.1.1.6.5 South Korea: Asia Pacific Infusion Devices Market Share - by End User
  - 10.1.1.7 Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.7.1 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Product Type
    - 10.1.1.7.2 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.7.3 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.7.4 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Application
    - 10.1.1.7.5 Rest of APAC: Asia Pacific Infusion Devices Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Infusion Devices Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Becton Dickinson and Co
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Fresenius Kabi AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 B Braun SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 CODAN US Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Elimedical Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 ICU Medical Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 BPL Medical Technologies Pvt Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Nipro Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 KD Scientific Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Medtronic Plc
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Zimed Healthcare Ltd
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Terumo Corp
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Eitan Medical Ltd
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 Polymedicure
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Financial Overview
- 12.15.4 SWOT Analysis
- 12.15.5 Key Developments
12.16 Moog Inc
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 Tandem Diabetes Care Inc
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments

13. Appendix

13.1 About The Insight Partners